ROTH Capital Partners Healthcare Investment Banking Team
Completes 39 Equity, Debt, and M&A Advisory Transactions in 2017

   

For more information, please contact:

James Antonopoulos
Managing Director &
Co-Head of Healthcare
Investment Banking
(646) 358-1906
jantonopoulos@roth.com

Eric B. Cheng
Managing Director &
Co-Head of Healthcare
Investment Banking
(646) 358-1901
echeng@roth.com

Ted Roth
President & Head of
Investment Banking
(949) 720-5753
troth@roth.com

Aaron M. Gurewitz
Managing Director &
Head of Equity
Capital Markets
(949) 720-5703
agurewitz@roth.com

SELECT 2017 HEALTHCARE TOMBSTONES

Source: ROTH Capital Partners | 1/4/18

  With Warmest Regards  
  Eric B. Cheng James Antonopoulos
  Managing Director &
Co-Head of Healthcare
Investment Banking
Managing Director &
Co-Head of Healthcare
Investment Banking

About ROTH Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.

Date of Announcement: 1/5/18

The material, information and  facts discussed in this announcement other than the information regarding ROTH Capital Partners, LLC ("ROTH") and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This announcement should not be used as a complete analysis of any companies, securities or topics discussed herein. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in this announcement are subject to change without notice. An investment in any security based on this announcement may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Additionally, such investments may involve a high degree of risk and may not be suitable for all investors. No part of this announcement may be reproduced in any form without the express written permission of ROTH. Copyright 2018.